Detalhe da pesquisa
1.
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
Blood
; 143(14): 1391-1398, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153913
2.
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study.
Haematologica
; 109(2): 431-443, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646665
3.
CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma.
Blood
; 138(24): 2499-2513, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166502
4.
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome.
JAMA
; 329(24): 2154-2162, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37367976
5.
Time-dependent analysis of adoptive immunotherapy following sequential FLAMSA-reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk myeloid neoplasia.
Eur J Haematol
; 108(3): 244-263, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902880
6.
Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan.
Haematologica
; 106(1): 196-207, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857361
7.
Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia.
Blood
; 131(14): 1522-1531, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29358182
8.
G-CSF administration prior to donor lymphocyte apheresis promotes anti-leukaemic effects in allogeneic HCT patients.
Br J Haematol
; 186(1): 60-71, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30916396
9.
Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Biol Blood Marrow Transplant
; 24(12): 2558-2567, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29966760
10.
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia.
Ann Hematol
; 97(12): 2491-2500, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30066039
11.
Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment.
Blood
; 126(24): 2578-84, 2015 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26480933
12.
Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation.
Ann Hematol
; 96(5): 817-827, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28247058
13.
Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation.
Clin Transplant
; 31(7)2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28470884
14.
Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies.
Ann Hematol
; 95(1): 115-124, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26411736
15.
Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience.
Ann Hematol
; 95(6): 973-83, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27021303
16.
Allogeneic hematopoietic cell transplantation for adult metachromatic leukodystrophy: a case series.
Blood Adv
; 8(6): 1504-1508, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330194
17.
Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device.
Cytotherapy
; 15(10): 1253-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23993299
18.
Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia.
Ann Hematol
; 92(10): 1389-95, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23652585
19.
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.
Blood
; 116(10): 1795-802, 2010 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-20530284
20.
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.
Haematologica
; 97(10): 1523-31, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22491731